Prestige Consumer Healthcare (PBH) EPS (Diluted) Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) EPS (Diluted) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.11% |
| Sep 30, 2025 | -5.49% |
| Jun 30, 2025 | -4.38% |
| Mar 31, 2025 | -0.77% |
| Dec 31, 2024 | 7.39% |
| Sep 30, 2024 | 6.82% |
| Jun 30, 2024 | -5.04% |
| Mar 31, 2024 | 11.99% |
| Dec 31, 2023 | 9.39% |
| Sep 30, 2023 | 6.71% |
| Jun 30, 2023 | 7.26% |
| Mar 31, 2023 | -105.32% |
| Dec 31, 2022 | 11.40% |
| Sep 30, 2022 | 15.76% |
| Jun 30, 2022 | 18.68% |
| Mar 31, 2022 | 33.57% |
| Dec 31, 2021 | 10.48% |
| Sep 30, 2021 | 14.70% |
| Jun 30, 2021 | 20.53% |
| Mar 31, 2021 | 43.36% |